A public consultation on the Module was conducted between October 2022 and February 2023. This document outlines the public consultation process and summarises participation and the feedback received.

Findings from the consultation process were used to inform amendments to the Module and will support the development of implementation resources.

This issue includes items on the National Safety and Quality Cosmetic Surgery Standards, the National Consensus Statement: Essential elements for safe and high-quality end-of-life care, health economics, patient safety, informed consent, disability, COVID-19, and more.

This fact sheet explains some actions for consumers and/or their carers take to help keep safe while using insulin. Insulins are available in different strengths and formulations or presentations with medicine names that look and sound similar. Consumers need to ‘stop, think and check’ that they have the right brand of insulin in the right strength before administering.

This factsheet highlights best practise dispensing to support safe and quality use of insulin, within the context of active ingredient prescribing. Safe and quality use of insulins requires clear information transfer from initial prescribing to the dispensing label, to ensure safe use by consumers and/or their carers.

The Commission has developed the National Safety and Quality Cosmetic Surgery Standards to ensure patients receive safe, high-quality care in facilities where cosmetic surgery is performed.

The Cosmetic Surgery Standards were released on 14 December 2023.